Clinical Trial Update: Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated radiotherapy with immunotherapy versus conventional radiotherapy for locally recurrent rectal cancer; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Locally Recurrent Rectal Cancer | Phase 2 | Status: RECRUITING